Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Recent Market Trends
     3.1 NHI Pharmacies and DPC Hospitals to Contribute Majorly in Generics
     3.2 Japan: Next Generic Hub for Pharma Majors
     3.3 Cancer Generics Projected for Exorbitant Growth

4. Demographics Profile

5. The Japanese Pharmaceutical Market Outlook to 2014

6. The Japanese Generic Drugs Market Overview
     6.1 Healthcare Expenditure
            6.1.1 Expenditure by Disease and Age Group
     6.2 Generics Penetration
     6.3 Generics Market Outlook to 2014
     6.4 Ethical vs OTC Generics
     6.5 Distribution System
            6.5.1 By Medical Institution
            6.5.2 By Distribution Channel
     6.6 Recent Generic Launches

7. Consumer Behavior Analysis
     7.1 Patients View
     7.2 Physicians and Pharmacist View

8. Regulatory Environment
     8.1 Role of MHLW
     8.2 Key Requirements for Generics Approval and Marketing Authorization
     8.3 Patent System

9. Key Government Initiatives

10. Opportunity Assessment
     10.1 By Patent Expiration
     10.2 By Therapeutic Treatment

11. Key Players
     11.1 Nichi-Iko
     11.2 Sawai Pharmaceuticals
     11.3 Taiyo Pharmaceutical
     11.4 Towa
     11.5 Meiji Seika
     11.6 Nippon Chemipher